EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IGF1 Signaling Regulates Neuropeptide Expression in Hypothalamic Neurons Under Physiological and Pathological Conditions

Wenyuan He, Neruja Loganathan, Denise D Belsham iD

Endocrinology · 2025

DOI: 10.1210/endocr/bqaf051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2025. Verfasst von Wenyuan He und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Toronto, Toronto, ON, Canada M5S 1A8. Hauptthemen laut MEDLINE: Hypothalamus, Insulin-Like Growth Factor I, Neurons, Neuropeptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSERC, Canada Foundation for Innovation, Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin-like growth factor 1 (IGF1) plays a critical role in metabolism and aging, but its role in the brain remains unclear. This study examined whether hypothalamic neurons respond to IGF1 and how its actions are modulated. RT-qPCR and single-cell RNA sequencing indicated that Igf1r mRNA is expressed in neuropeptide Y/Agouti-related peptide (NPY/AgRP) neurons but has higher expression in pro-opiomelanocortin (POMC) neurons. IGF1 binding proteins Igfbp3 and Igfbp5 were significantly expressed, whereby Igfbp5 levels were modulated by fasting, nutrient availability, and circadian rhythms, implying that IGF1 signaling can be controlled by multiple mechanisms. In mouse and human models, IGF1 regulated Agrp, Npy, Pomc, Cartpt, Spx, Gal, and Fam237b expression, producing an overall anorexigenic profile. Hyperinsulinemia induced IGF1 resistance, accompanied by reduced IGF1R protein, as well as Igf1r and Irs2 mRNA expression via over-activation of phosphoinositide 3-kinase/forkhead box O1 (PI3K-FOXO1) signaling. Thus, hypothalamic neurons respond to IGF1 under physiological conditions, and hyperinsulinemia is a novel mechanism that drives cellular IGF1 resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothalamusInsulin-Like Growth Factor INeuronsNeuropeptidesAnimalsSignal TransductionMiceHumansMalePro-OpiomelanocortinAgouti-Related ProteinReceptor, IGF Type 1Neuropeptide YMice, Inbred C57BLHyperinsulinismGene Expression RegulationInsulin-Like Growth Factor Binding Protein 3

Stichwörter der Autor:innen

IGF1IGF1 resistancehyperinsulinemiahypothalamusinsulinneuropeptides

Substanzen

Insulin-Like Growth Factor IPro-OpiomelanocortinAgouti-Related ProteinNeuropeptidesReceptor, IGF Type 1Neuropeptide YInsulin-Like Growth Factor Binding Protein 3Igf1r protein, mouse

Autor:innen und Institutionen

  • Department of Physiology, University of Toronto, Toronto, ON, Canada M5S 1A8.
  • Department of Medicine, University of Toronto, Toronto, ON, Canada M5S 1A8.
  • Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada M5S 1A8.

ORCID-Profile: Denise D Belsham

Förderung

  • NSERC
  • Canada Foundation for Innovation
  • Canada Research Chairs
  • CGS

Zitieren

APA

He, W., Loganathan, N., & Belsham, D. D. (2025). IGF1 Signaling Regulates Neuropeptide Expression in Hypothalamic Neurons Under Physiological and Pathological Conditions. Endocrinology. https://doi.org/10.1210/endocr/bqaf051

Vancouver

He W, Loganathan N, Belsham DD. IGF1 Signaling Regulates Neuropeptide Expression in Hypothalamic Neurons Under Physiological and Pathological Conditions. Endocrinology. 2025. doi:10.1210/endocr/bqaf051

BibTeX
@article{He2025,
  author = {He, Wenyuan and Loganathan, Neruja and Belsham, Denise D},
  title = {IGF1 Signaling Regulates Neuropeptide Expression in Hypothalamic Neurons Under Physiological and Pathological Conditions},
  journal = {Endocrinology},
  year = {2025},
  doi = {10.1210/endocr/bqaf051}
}
Kostenlos starten →